| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ddcf2c315c108125b002b152dccca9cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2020-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f77d6f83ba723d8627817b4d341f7f07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2857b8f075f4355289d3c739fd4f49b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d302d770c64420541094c670b643067 |
| publicationDate |
2021-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021025554-A1 |
| titleOfInvention |
Combination comprising an activator of the glucocorticoid receptor and an inhibitor of ifg-1 signaling for carcinoma treatment |
| abstract |
The invention relates to a combination of an activator of glucocorticoid receptor (GR) and an inhibitor of insulin like growth factor 1 (IGF1) signaling, for use as a medicament. The invention further relates to a kit of parts and to a pharmaceutical composition comprising an activator of GR and an inhibitor of IGF1 signaling, preferably for use in a method of treating a cancer. |
| priorityDate |
2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |